Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases  by Matsui, Takeshi et al.
Brief Communication 1259
Activation of ERM proteins in vivo by Rho involves phosphatidyl-
inositol 4-phosphate 5-kinase and not ROCK kinases
Takeshi Matsui*, Shigenobu Yonemura*, Shoichiro Tsukita*
and Sachiko Tsukita*†
When activated, ERM (ezrin, radixin, moesin) proteins
are recruited to the plasma membrane, with
concomitant carboxy-terminal threonine
phosphorylation, where they crosslink actin filaments to
the plasma membrane to form microvilli (reviewed in
[1–5]). Here, we report that, when NIH3T3 or HeLa cells
were transfected with a constitutively active mutant of
the small GTPase RhoA (V14RhoA), microvilli were
induced and the level of carboxy-terminal threonine-
phosphorylated ERM proteins (CPERM) [6,7] increased
~30-fold. This increase was not observed following
transfection of constitutively active forms of two other
Rho-family GTPases, Rac1 and Cdc42, or of a direct
effector of Rho, Rho-kinase (also known as ROKα or
ROCK-II) [8–10]. The V14RhoA-induced phosphorylation
of ERM proteins was not suppressed by Y-27632, a
specific inhibitor of ROCK kinases including Rho-kinase
[11]. Overexpression of another direct effector of Rho,
phosphatidylinositol 4-phosphate 5-kinase (PI4P5K)
type Iα [12–14], but not a kinase-inactive mutant [15],
increased ~sixfold the level of CPERM, and induced
microvilli. Together with the previous finding that the
PI4P5K product phosphatidylinositol 4,5-bisphosphate
(PIP2) activates ERM proteins in vitro [16], our data
suggest that PIP2, and not ROCK kinases, is involved in
the RhoA-dependent activation of ERM proteins in vivo.
The active state of ERM proteins is maintained through
threonine phosphorylation by as yet undetermined
kinases, leading to microvillus formation.
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Results and discussion
Using monoclonal antibody 297S, which is specific for
ezrin, radixin and moesin that have been phosphorylated
on threonine residues 567, 564 and 558, respectively, we
have shown that stimulation of serum-starved Swiss 3T3
cells with lysophosphatidic acid (LPA) increases the level
of CPERM [7]. To examine the specificity of Rho family
members in ERM protein phosphorylation in vivo,
Myc-epitope-tagged constitutively active mutants of RhoA
(Myc–V14RhoA), Rac1 (Myc–V12Rac1) and Cdc42
(Myc–V12Cdc42) were transfected into NIH3T3 cells
using LipofectAMINE PLUS reagent (GIBCO BRL).
Around 12 hours after transfection, the cells were serum-
starved for 6 hours, followed by trichloroacetic acid fixation
[17] and immunofluorescence staining with monoclonal
antibody 297S (Figure 1). No significant CPERM signals
were detected in cells expressing either Myc–V12Cdc42 or
Myc–V12Rac1 (Figure 1a–d), nor in non-transfected and
mock-transfected cells, although ERM proteins were
diffuse in the cytoplasm as shown by anti-ERM polyclonal
antibody TK89 [7] (data not shown). In Myc–V14RhoA-
expressing cells, microvilli significantly increased in
number as shown by antibody TK89 (data not shown), and
there was a marked increase in the amount of CPERM
concentrated in microvilli (Figure 1e,f). Thus, microvillus
Figure 1
Rho-specific phosphorylation of ERM proteins in NIH3T3 cells.
NIH3T3 cells transiently expressing (a,b) Myc–V12Cdc42,
(c,d) Myc–V12Rac1, or (e,f) Myc–V14RhoA were serum-starved for
6 h, then double-stained with (a,c,e) anti-Myc polyclonal antibody and
(b,d,f) anti-CPERM monoclonal antibody 297S. (f) Only V14RhoA
increased the levels of CPERM, which were recruited to microvilli. The
scale bar represents 10 µm. 
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formation by recruitment of CPERM is downstream of
Rho, and not Rac or Cdc42. This conclusion is consistent
with a recent study by Shaw et al. [18] who showed that
V14RhoA induced the translocation and phosphorylation of
ERM proteins, although it was not determined which
amino-acid residues were phosphorylated.
We have also shown that a Rho-kinase directly phosphory-
lates the carboxy-terminal threonines of ERM proteins
in vitro [7]. To determine whether the Rho-kinase is also
directly involved in the RhoA-dependent production of
CPERM in vivo, the catalytic domain (amino acids 6–553)
of the kinase (Rho-Kc) [19], which on its own is constitu-
tively active, was transfected into NIH3T3 cells. In the
cells expressing Rho-Kc with a stellate morphology,
microvillus formation did not appear to be induced and no
significant increase was detected in the amount of
CPERM (see Supplementary material). 
Next, we examined the effects of the ROCK inhibitor
Y-27632 [11] on the Rho-dependent induction of CPERM
and microvillus formation in vivo. When serum-starved
NIH3T3 cells expressing Myc–V14RhoA were treated
with 20 µM Y-27632, the Myc–V14RhoA-induced forma-
tion of stress fibers and focal contacts was completely sup-
pressed (see Supplementary material), indicating that the
activity of ROCK kinases was inhibited by Y-27632. In
marked contrast, the Myc–V14RhoA-dependent induction
of CPERM and microvillus formation were not affected
by Y-27632 (Figure 2e–h; see also Supplementary mater-
ial). Thus, ROCK kinases including Rho-kinase, are not
directly involved in the induction of CPERM or micro-
villus formation in vivo. These results contradict a recent
report by Oshiro et al. [20] who found that overexpression
of a constitutively active Rho-kinase induced the forma-
tion of microvilli-like structures in COS7 cells. This effect
might have been due to the overexpression of the hemag-
glutinin (HA)-tagged moesin fusion protein in their study.
Next, we examined whether PI4P5K type Iα [12–14],
another direct effector of Rho, is involved in the
1260 Current Biology Vol 9 No 21
Figure 2
Effects of the ROCK inhibitor Y-27632 on V14RhoA-induced
formation of CPERM-containing microvilli. NIH3T3 cells transiently
expressing Myc–V14RhoA were serum-starved and incubated in the
(a,c,e,g) absence or (b,d,f,h) presence of 20 µM Y-27632 for 30 min,
then double-stained with anti-Myc monoclonal antibody 9E10 or
polyclonal antibody (see Supplementary material) and
(a,b) rhodamine–phalloidin, (c,d) anti-vinculin monoclonal antibody,
(e,f) anti-ERM polyclonal antibody TK89 or (g,h) anti-CPERM
monoclonal antibody 297S. Y-27632 suppressed completely the
formation of (a,b) stress fibers and (c,d) focal contacts, but did not
affect the (e–h) V14RhoA-induced formation of CPERM-containing
microvilli. The scale bars represent 10 µm.
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Figure 3
PI4P5K-specific induction of microvilli containing CPERM. NIH3T3 cells
transiently overexpressing (a,b) HA×3–PI4P5K or (c,d) its kinase-inactive
mutant were serum-starved, then double-stained with (a,c) anti-HA
polyclonal antibody and (b,d) anti-CPERM monoclonal antibody 297S.
(a,b) PI4P5K did not induce the formation of stress fibers or focal
contacts (see Supplementary material), but mimicked the V14RhoA-
induced formation of microvilli containing CPERM (see also Figure 1).
(c,d) In contrast, the kinase-inactive mutant HA×3–K138API4P5K did not
increase the level of CPERM. The scale bars represent 10 µm.
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Rho-dependent induction of CPERM and/or microvillus
formation in vivo. The forced expression of a PI4P5K
fusion protein with three amino-terminal HA tags
(HA×3–PI4P5K) did not affect stress fibers or focal con-
tacts in NIH3T3 cells (see Supplementary material).
Instead, in these PI4P5K-overexpressing cells, ERM pro-
teins were significantly recruited to plasma membranes to
form microvilli, where CPERM were concentrated
(Figure 3a,b). Overexpression of a kinase-inactive mutant
of PI4P5K in which the Lys138 residue was substituted
with alanine (HA×3–K138API4P5K; [15]) did not induce
such changes (Figure 3c,d), suggesting that the RhoA-
dependent induction of CPERM and microvillus forma-
tion in vivo required kinase activity of PI4P5K. Even in
the presence of Y-27632, HA×3–PI4P5K-expressing cells
showed enhanced levels of CPERM and a large number of
microvilli on their surface (see Supplementary material),
thereby excluding the possibility of crosstalk from PI4P5K
to ROCK kinases (see also Supplementary material). 
To validate the immunofluorescence data, we quantitated
the change in the level of CPERM induced by transfection
of Myc–V14RhoA or HA–PI4P5K. As in NIH3T3 cells,
the level of CPERM was enhanced in HeLa cells that
were transiently transfected with HA×3–V14RhoA or
HA×3–PI4P5K (see Supplementary material). Because it
was impossible to establish stable transfectants of these cells
and the efficiency of transient transfection was higher in
HeLa cells than that in NIH3T3 cells, we used HeLa cells
transiently expressing Myc–V14RhoA or HA–PI4P5K to
quantitate the level of CPERM by a densitometric scan of
CPERM-immunoblotted bands in five independent experi-
ments, as described previously [7]. When HeLa cells were
transfected with Myc–V14RhoA using the LipofectAMINE
PLUS reagent, ~10% of cells were transfected, as deter-
mined by Myc immunofluorescence; the total level of
CPERM was ~threefold higher than in mock-transfected
cells for all ERM proteins, as shown by immunoblotting,
suggesting that the level of CPERM was enhanced ~30-fold
by transfection of Myc–V14RhoA (Figure 4a). 
Next, we transfected HeLa cells with HA–PI4P5K by
adenovirus-mediated gene transfer; the transfection effi-
ciency was ~90% in all cells, as judged by HA immuno-
fluorescence (data not shown). Immunoblotting of the
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Figure 4
Increase in the level of CPERM induced by
V14RhoA and by PI4P5K, as estimated by
immunoblotting. (a) HeLa cells transiently
expressing Myc–V12Cdc42, Myc–V12Rac1
or Myc–V14RhoA. The immunoblotting was
probed with antibodies against CPERM,
ERM and Myc. The level of CPERM was
substantially enhanced by the transfection of
Myc–V14RhoA. (b) HeLa cells transiently
expressing HA–PI4P5K or its kinase-inactive
mutant HA–K138API4P5K. The immunoblot
was probed with antibodies against CPERM,
ERM and HA. Immunoblotting revealed that
the transfection of HA–PI4P5K, but not
HA–K138API4P5K, induced a ~sixfold
increase in the level of CPERM, as compared
with lacZ-transfected control cells. Y-27632
did not affect the level of CPERM in cells
expressing either lacZ or HA–PI4P5K.
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Figure 5
A model for the Rho-dependent regulation of ERM proteins and
microvillus formation. Some extracellular stimuli, such as LPA, activate
Rho, and several distinct signaling pathways originating from active
Rho regulate the organization of the actin cytoskeleton. Rho-
dependent activation of PI4P5K results in the elevation of PIP2 levels,
which may open the closed form of dormant ERM proteins allowing
phosphorylation of their carboxy-terminal threonine residue by an as yet
unidentified kinase(s), such as protein kinase C-θ (PKC-θ) which
reportedly increases the level of CPERM in vitro [26]. In the open
configuration, CPERM are stable and crosslink actin filaments with the
plasma membrane [16,27] to form microvilli. As previously reported,
activated ERM proteins provide positive feedback to Rho: CPERM
bind to Rho–GDP dissociation inhibitor (Rho-GDI), which is
complexed with GDP–Rho [16]. By this binding the Rho-GDI activity is
inhibited, resulting in release of GDP–Rho from Rho-GDI followed by
the activation to GTP–Rho [28]. ROCK kinases are not involved in this
Rho-dependent microvillus formation, but are known to be involved in
the formation of stress fibers and focal contacts. It is likely that
activated ERM proteins and other Rho-dependent signaling pathways
are also synergistically involved in stress fiber/focal contact formation
together with ROCK kinases.
Rho
Rho-GDI
Signals
Other targets
?
? Stress fiber/focal contactformation
Microvillus formation
Rho PI4P5K PIP2
ROCK kinases Y-27632
Inactive
Active (CPERM)
Kinases ?
GTP
ERM
ERM
Rho-GDI
GDP
Current Biology   
transfectants revealed that transfection of HA–PI4P5K
induced a ~sixfold increase in the level of CPERM as
compared with lacZ-transfected control cells, as estimated
in five independent experiments (Figure 4b). Overexpres-
sion of the kinase-inactive mutant HA–K138API4P5K did
not increase the level of CPERM, and Y-27632 did not
have an effect on the level of CPERM in either lacZ-
expressing or HA–PI4P5K-expressing cells. These results
are thus consistent with the immunofluorescence results. 
Our results suggest a model for RhoA-dependent activa-
tion of ERM proteins in vivo (Figure 5). The activation by
PIP2 and stabilization by phosphorylation of ERM proteins
would also be important for stress fiber/focal contact forma-
tion [21]; Takeuchi et al. [22] and Mackay et al. [23] have
reported that at least one of the ERM proteins is required
for the Rho-dependent formation of stress fibers and focal
contacts. Furthermore, mDia, another direct effector of
Rho, has also been reported to be involved in stress
fiber/focal contact formation synergistically with ROCK
kinases [24,25]. Therefore, several distinct lines of signal-
ing originating from activated Rho are integrated into the
formation of stress fibers and focal contacts (Figure 5).
Supplementary material
Supplementary material including additional methodological detail and
figures is available at http://current-biology.com/supmat/supmatin.htm.
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Supplementary materials and methods 
Antibodies and cultured cells
Anti-ERM polyclonal antibody (TK89) detects the carboxy-terminal halves
of all ERM proteins [S1]. Mouse anti-CPERM monoclonal antibody 297S
specifically recognizes T567-phosphorylated ezrin, T564-phosphorylated
radixin and T558-phosphorylated moesin [S1]. Mouse anti-Myc mono-
clonal antibody (9E10) and mouse anti-HA monoclonal antibody
(12CA5) were purchased from Boehringer Mannheim Biotechnology.
Rabbit anti-Myc polyclonal antibody, rabbit anti-HA polyclonal antibody
and mouse anti-vinculin monoclonal antibody (hVIN1) were purchased
from Santa Cruz, MBL and Sigma Chemicals, respectively. Mouse
NIH3T3 cells and human HeLa cells were cultured in DME supple-
mented with 10% FCS. Some cells were cultured in the presence of Y-
27632, which was kindly provided by S. Narumiya (Kyoto University) and
Yoshitomi Pharmaceutical Industries Ltd.
Cloning of cDNA for PI4P5K type Iα
Mouse lung total RNA was isolated according to the method described
by Chomczynski and Sacchi [S2]. First strand cDNA was prepared
with SuperscriptTM II reverse transcriptase (GIBCO BRL). Using this
first strand cDNA as a template, a full-length cDNA encoding mouse
PI4P5K type Iα was amplified by PCR with two primers, 5′-ATTA-
GATATCATGTCGTCAACTGCTGAAAATG-3′ and 5′-TAATGATATC-
CACTTATAAATAGACGTCCAGCAC-3′ [S3], and subcloned into the
pGEM-T Easy vector (Promega) to yield pGEM-PI4P5K. The cDNA for
the kinase-inactive mutant K138API4P5K was generated by subcloning
the mutant cDNA fragment which was obtained by PCR with two primers
5′-ATGAATTTATCATCGCGACCGTTCAG-3′ (underlined nucleotides
encode a mutated alanine) and 5′-ATGATAAATTCATCATCGCTGGTC-
3′ into pGEM-PI4P5K to yield pGEM-K138API4P5K [S4]. 
Mammalian expression vectors 
Expression vectors (pEF-BOS) for Myc–V14RhoA, Myc–V12Rac1 and
Myc–V12Cdc42 were generous gifts from Y. Takai (Osaka University),
and Rho-Kc was kindly provided from K. Kaibuchi (Nara Institute of
Science and Technology). To express HA×3–V14RhoA, its cDNA was
excised from pEF-BOS-Myc–V14RhoA by BamHI digestion, and sub-
cloned into pEF-BOS-HA×3 to yield pEF-BOS-HA×3–V14RhoA. To
express HA×3-PI4P5K type Iα or HA×3–K138API4P5K type Iα, their
cDNAs were excised from pGEM-PI4P5K or pGEM-K138API4P5K by
EcoRV digestion and subcloned into pEF-BOS-HA×3 to yield pEF-
BOS-HA×3–PI4P5K or pEF-BOS-HA×3–K138API4P5K, respectively.
For mock transfection, pEF-BOS-Myc or pEF-BOS-HA×3 was used.
Recombinant adenovirus encoding HA–PI4P5K and HA–K138API4P5K
were generous gifts from Y. Shibasaki (Tokyo University) [S3,S4].
The control virus (Adex1CAlacZ) was kindly provided by I. Saito
(Tokyo University) [S5]. 
Transfection
NIH3T3 cells or HeLa cells cultured on glass coverslips were trans-
fected with each plasmid using LipofectAMINE PLUS reagent (GIBCO
BRL) according to the manufacturer’s instructions. After 12 h, NIH3T3,
but not HeLa cells, were starved of serum for 6 h and then examined by
immunofluorescence microscopy or immunoblotting. In some experi-
ments, cells were treated with 20 µM Y-27632 for 30 min at 37°C to
suppress ROCK kinases before fixation. Adenovirus infection was
carried out as described previously [S3,S5]. Briefly, HeLa cells
(1 × 105 cells) seeded on 3.5 cm dishes were infected with a recombi-
nant adenovirus (3–5 × 107 plaque-forming units) and 24 h later, cells
were subjected to immunoblotting.
Immunofluorescence microscopy
For immunofluorescence staining with anti-ERM polyclonal antibody
TK89 or anti-CPERM monoclonal antibody 297S, transfected cells on
glass coverslips were fixed with 10% trichloroacetic acid (TCA) on ice
for 10 min [S6]. For other antibodies, cells were fixed with 3% formalde-
hyde for 10 min followed by 5 min treatment with 0.1% Triton X-100 in
PBS. After washing three times with PBS, cells were soaked in a block-
ing solution (PBS containing 1% BSA) for 10 min and incubated with the
first antibody for 1 h. Cells were then washed three times with PBS,
incubated with secondary antibodies (Cy2-conjugated anti-mouse IgG,
Supplementary material
Figure S1
Effects of forced expression of Rho-Kc. NIH3T3 cells transiently
expressing Rho-Kc exhibited a stellate morphology. These cells were
starved of serum, then doubly stained with (a,b) rhodamine–phalloidin
and anti-vinculin monoclonal antibody, (c,d) rhodamine–phalloidin and
anti-ERM polyclonal antibody (TK89), or (e,f) anti-ERM polyclonal
antibody (TK89) and anti-CPERM monoclonal antibody (297S). Rho-Kc
increased (b) the number of vinculin-positive focal contacts, and (a,c)
stellately arranged actin filament bundles. (d,e) ERM proteins were not
recruited to plasma membranes, and (f) the levels of CPERMs were not
elevated. The scale bar represents 10 µm.
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Cy2-conjugated anti-rabbit IgG, Cy3-conjugated anti-mouse IgG, Cy3-
conjugated anti-rat IgG, Cy3-conjugated anti-rabbit IgG and rho-
damine–phalloidin) for 30 min, washed with PBS three times, then
mounted in 90% glycerol–PBS containing 0.1% p-phenylendiamine and
1% n-propylgalate. Specimens were observed using a Zeiss Axiophot
photomicroscope (Carl Zeiss). Images were recorded with a cooled
CCD camera (SenSys 0400, 768 × 512 pixels; Photometrics) controlled
by a Power Macintosh 7600/132 and the IPLab Spectrum V3.1 software
package (Signals Analytics).
Immunoblotting 
Transfected cells in 6 cm culture dishes were fixed with 10% TCA and
washed with PBS three times and then solubilized with 50 µl of
SDS–PAGE sample buffer. After sonication, samples were resolved by
SDS–PAGE according to the method of Laemmli [S7], and transferred
to a polyvinylidene difluoride (PVDF) membrane (Immobilon; Millipore),
followed by immunoblotting with TK89, 297S and anti-Myc antibodies.
Bound antibodies were visualized with alkaline-phosphatase-conjugated
goat anti-rabbit IgG or anti-rat IgG and the appropriate substrates as
described by the manufacturer (Amersham International). The bands
were quantified by densitometric scanning and were compared with the
control samples of ERM proteins with the determined amounts [S1]. 
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Figure S3
PI4P5K-specific induction of microvilli containing CPERM in NIH3T3
cells. (a–d) NIH3T3 cells transiently overexpressing HA×3–PI4P5K
(arrowheads), with untransfected cells in the vicinity of the
overexpressing cells, were starved of serum and incubated in the (a,b)
absence or (c,d) presence of 20 µM Y-27632 for 30 min. Cells were
then doubly stained with (a,c) anti-HA polyclonal antibody and (b,d) anti-
CPERM monoclonal antibody 297S. (a,b) Overexpression of PI4P5K
induced formation of microvilli containing CPERM. (c,d) Y-27632 did
not affect the PI4P5K-induced formation of microvilli containing
CPERM. (e–h) When NIH3T3 cells transiently overexpressing HA×3-
tagged PI4P5K were serum-starved, then double-stained with (e,g) anti-
HA polyclonal antibody, (f) rhodamine–phalloidin and (h) anti-vinculin
monoclonal antibody, PI4P5K did not induce the (e,f) formation of
stress fibers or (g,h) focal contacts. The scale bars represent 10 µm. Current Biology  
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Figure S2
Effects of Y-27632, a potent inhibitor of ROCK
kinases including Rho-kinase, on V14RhoA-
induced formation of microvilli containing
CPERM. NIH3T3 cells transiently expressing
Myc–V14RhoA were starved of serum and
incubated in the (a,b,e,f,i,j,m,n) absence or
(c,d,g,h,k,l,o,p) presence of 20 µM Y-27632
for 30 min, then doubly stained with
(a,c,i,k) anti-Myc monoclonal antibody 9E10 or
(e,g,m,o) anti-Myc polyclonal antibody and
(b,d) rhodamine–phalloidin, (f,h) anti-vinculin
monoclonal antibody, (j,l) anti-ERM polyclonal
antibody TK89 or (n,p) anti-CPERM
monoclonal antibody (297S). Y-27632
completely suppressed the formation of
(a–d) stress fibers and (e–h) focal contacts,
but did not affect the (i–p) V14RhoA-induced
formation of microvilli containing CPERM. The
scale bars represent 10 µm.
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Figure S4
Induction of microvilli and production of CPERM in HeLa cells by Rho
and PI4P5K. HeLa cells transiently expressing (a,b) HA×3–V14RhoA,
(c,d) HA×3–PI4P5K or (e,f) the kinase-inactive mutant
HA×3–K138API4P5K were doubly stained with (a,c,e) anti-HA
polyclonal antibody and (b,d,f) anti-CPERM monoclonal antibody 297S.
In the cells expressing (a,b) HA×3-V14RhoA or (c,d) HA×3-PI4P5K, the
level of CPERM was increased. CPERM levels were higher in
(b) HA×3–V14RhoA-expressing cells than in (d) HA×3–PI4P5K-
expressing cells. (f) HA×3–K138API4P5K did not induce CPERM.
The scale bar represents 10 µm.
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